AMGN ▼ -1.8% - Amgen Inc.
$AMGN AMGN - IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
24-OCT-2026 10:30 AM ET
Share this post
More filings for $AMGN
AMGN ▼ -1.3% - Amgen Inc.Nov 11, 2026AMGN ▲ +1.0% - Amgen Inc.Nov 9, 2026AMGN ▲ +0.4% - Amgen Inc.Nov 9, 2026AMGN ▼ -2.4% - Amgen Inc.Nov 6, 2026AMGN ▲ +1.4% - Amgen Inc.Nov 5, 2026AMGN ▲ +0.3% - Amgen Inc.Nov 5, 2026
View full $AMGN filing history →💬 Comments
Loading comments…
Leave a comment
